stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Free - Play StoreApp Store
InstallInstall
logo
Vertex Pharmaceuticals IncVRTX
$525.422.06%-11.03

Vertex Pharmaceuticals Inc (VRTX)

Vertex Pharmaceuticals Inc Stock (VRTX) Financials Data

*All numbers in millions
Period End Date2026-09-302026-06-302026-03-312025-12-312025-09-30
Period Length3 Months3 Months3 Months3 Months3 Months
Revenues
3.21%3,440.80
3,333.902,986.903,190.003,076.40
Cost Of Revenue
7.54%526.10
489.20392.80466.00414.80
44.98%844.10
582.20493.70--
Selling, General, and Administrative
44.98%844.10
582.20493.70--
Costs And Expenses
30.71%2,727.90
2,087.001,848.801,984.101,890.20
Operating Income/Loss
42.83%712.90
1,246.901,138.101,205.901,186.20
Income/Loss From Continuing Operations Before Tax
43.71%783.40
1,391.801,252.901,331.001,298.80
Income Tax Expense/Benefit
55.55%129.80
292.00221.50139.90215.90
40.57%653.60
1,099.801,031.401,191.101,082.90
Attributable To Parent
40.57%653.60
1,099.801,031.401,191.101,082.90
Basic Average Shares
0.08%253.50
253.70254.10-0.70255.60
Diluted Average Shares
255.20
255.20256.30-0.60257.60
Basic Earnings Per Share
40.55%2.58
4.344.064.694.24
Diluted Earnings Per Share
40.60%2.56
4.314.024.644.20

Similar to VRTX